Stelara 45 MG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FLVZR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,653
Award facts
- Contract value 100% obligated
- $14,652.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on September 16, 2025, for the supply of Stelara 45 mg/0.5 ml syringes. The contract has a ceiling value of $14,652.58 and is scheduled for completion by September 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through competitive procurement. The award represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $1 billion pharmaceutical support vehicle valued through December 2026 that enables the company to supply pharmaceuticals and medical supplies to military healthcare programs globally.
The delivery order fulfills medical procurement needs within DLA's broader mission to support military and veteran healthcare systems. Stelara is an immunosuppressant medication used to treat various inflammatory conditions and represents the type of specialized pharmaceutical product that AmerisourceBergen Drug Corp routinely delivers through its federal contract portfolio. The company's demonstrated capability to manage both large-value IDC vehicles and smaller transactional delivery orders across multiple therapeutic domains underscores its role as a critical vendor in the federal medical supply chain, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FLVZR?
SPE2DB25FLVZR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FLVZR worth?
The government has obligated $14,653 on SPE2DB25FLVZR.
Is contract SPE2DB25FLVZR an order under another contract?
Yes. SPE2DB25FLVZR is a delivery order under SPE2DB22D6029, an indefinite delivery contract.
Was contract SPE2DB25FLVZR competed?
The extent of competition for SPE2DB25FLVZR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award